The biotech sector has outperformed the overall stock market over the past half-decade, due to increased healthcare spending on, exciting new areas of drug development and robust M&A activity.
The biotech sector has outperformed the overall stock market over the past half-decade, due to increased healthcare spending on, exciting new areas of drug development and robust M&A activity.